Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Shorts trying hard to contain it
View:
Post by ScienceFirst on Aug 18, 2022 9:38am

Shorts trying hard to contain it

Why would one dump below the last trade! Lolll
Comment by 99942Apophis on Aug 18, 2022 9:58am
ScienceFirst wrote Why would one dump below the last trade! Lolll One of many possible answers is if you are a potential buyer of the company ( Theralase  ) and you have already bought a large chunk of shares by keeping the share price low then your presented offer for the company will be considerably lower than its actual value. Is this legal or is it strategic buying? 
Comment by skys1 on Aug 18, 2022 10:36am
Apophis, That doesn't make sense. If you are a potential suitor of TLT and you buy a "large chunk of shares by keeping the price low". If you buy a large chuck of shares, you will be forcing the price not.up, not down.
Comment by 99942Apophis on Aug 18, 2022 10:42am
Sorry skys1 I should've added over a long period of time , you are correct if it was done in a 1 or 2 day period it would propel the price upward..
Comment by StevenBirch on Aug 18, 2022 10:59am
Also, offers to buy the company are not based on share price but future value of what the company is worth based on what it is selling even though they often get presented in a price per share manner, that just makes it easier for the market to digest. So if someone decides to buy the company it will be for a $ amount and it won't matter if it's trading at 30 cents or 3 dollars. Keeping it ...more  
Comment by steamfitter on Aug 18, 2022 11:03am
It's like using chum in the ocean. Throwing a bucket of fish guts to attract a greater ketch of fish. Selling shares down does the same thing they have hoped for. On a major day throwing cheap shares into the market to attract others in fear that their shares will go down much lower. What has happened to the shorters, NO one is selling their shares cheap. So they have had to increase the ...more  
Comment by Legit62 on Aug 18, 2022 11:19am
All hells going to break loose when TLT shows its hand, until then the games roll on with this shorting
Comment by Legit62 on Aug 18, 2022 11:20am
the overall volume is rediculously low, once we get some traction this volume will be in multiples of what is now
Comment by FGPstock on Aug 18, 2022 10:53am
SKYS1; i think he is making the argument that if someone wants to buyout tlt, their buyout premium would look better if the stock is at .25 than .75. Personally, i think it is just a lack of buying. but at this point yesterday there were bascially no shares traded then a flurry after 3pm, so its still early. I am thinking of trasnferring some money over and making a last buy if there is actually ...more  
Comment by Oilminerdeluxe on Aug 18, 2022 10:57am
If the next update is good, I am quite certain there will be a load of buyers. Just needs to be convincing. Sounds so easy...
Comment by skys1 on Aug 18, 2022 10:58am
But FGP, by buying that "large chunk" of shares to buy the company, the price p\s would be forced up killing that theory. Which would in practice make the cost of the take over, more expensive not less.
Comment by FGPstock on Aug 18, 2022 11:18am
skys1, i think we are saying the same thing. i thought it was a reference to shorting to cap the price. regardless, i don't think that is the case, hopefully there will be another flurry of buying this afternoon.
Comment by ScienceFirst on Aug 18, 2022 1:25pm
We'll have another (spike) as we get closer to August 31, given the few sellers. And a permanent one on good clinical data.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250